Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report

We report a case of minimal change disease (MCD) with severe acute kidney injury (AKI) following the first injection of the ChAdOx1 nCoV-19 (AZD1222) vaccine from Oxford-AstraZeneca against coronavirus disease 2019 (COVID-19). A 71-year-old man with a history of dyslipidemia and a baseline serum cre...

Descripción completa

Detalles Bibliográficos
Autores principales: Leclerc, Simon, Royal, Virginie, Lamarche, Caroline, Laurin, Louis-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the National Kidney Foundation, Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260495/
https://www.ncbi.nlm.nih.gov/pubmed/34242687
http://dx.doi.org/10.1053/j.ajkd.2021.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260495/
https://www.ncbi.nlm.nih.gov/pubmed/34242687
http://dx.doi.org/10.1053/j.ajkd.2021.06.008

Ejemplares similares